SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017162
Filing Date
2024-06-17
Accepted
2024-06-17 16:13:24
Documents
2
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 form4-06172024_080620.html 4  
1 form4-06172024_080620.xml 4 4334
2 ex24-06172024_080620.htm EX-24 6137
  Complete submission text file 0001415889-24-017162.txt   11914
Mailing Address NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
RIEFLIN WILLIAM JL (Reporting) CIK: 0001182471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 241048358

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)